🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Visualization of the HIV-1 Env glycan shield across scales

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2000260117Source: DataRank Database

Visualization of the HIV-1 Env glycan shield across scales is a research paper published in Proceedings of the National Academy of Sciences (2020). On theSindex it has a DataRank of 0.694. It has been cited 101 times.

N/A

0.694DataRank · unranked

Scored on demand from live citation data

Open Access101 citations

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 7.29)OA: hybridTopics (71)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.694

From this paper's citation signal

Citation Network Contribution

0

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (12)

Srirupa Chakraborty ORCID,Xiaoning Wang ORCID,Christopher A. Cottrell ORCID,Jonathan L. Torres ORCID,Jolene K. Diedrich ORCID

Live enrichment

PubMed:33093196 PMC:PMC7668054 OpenAlex:https://openalex.org/W3094127650

Bill and Melinda Gates Foundation

Grant: OPP1100639

Bill and Melinda Gates Foundation

Grant: OPP1115782

Bill and Melinda Gates Foundation

Grant: OPP1196345

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: UM1 AI100663

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: UM1 AI144462

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: AI113867

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: P41GM103533

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: UM1 AI100645

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: UM1 AI144371

NIAID NIH HHS

Grant: R01 AI113867

NIAID NIH HHS

Grant: F31 AI131873

NIAID NIH HHS

Grant: R56 AI113867

National Institutes of Health

Grant: 3P41GM103533-20S2

Comprehensive Biology: Exploiting the Yeast Genome

National Institutes of Health

Grant: 5UM1AI144371-02

Induction of protective antibodies for HIV vaccine development

National Institutes of Health

Grant: 5UM1AI100645-06

Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery

National Institutes of Health

Grant: 5UM1AI100645-03

Nonhuman primate scientific research support component

National Institutes of Health

Grant: 1R01AI113867-01

Glycan dependent epitopes of HIV broadly neutralizing antibodies

National Institutes of Health

Grant: 3UM1AI144371-06S1

Nonhuman primate studies for development of a prototype HIV vaccine that induces broadly neutralizing antibodies

National Institutes of Health

Grant: 3UM1AI100663-04S1

Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery

National Institutes of Health

Grant: 3UM1AI144462-02S1

Identification of neutralizing epitopes on SARS-CoV-2 spike for design of vaccines and small-molecule antivirals

FWCI

7.29

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://www.pnas.org/content/pnas/117/45/28014.full.pdf

publisherhttps://www.pnas.org/content/pnas/117/45/28014.full.pdf

publisherhttp://www.pnas.org/syndication/doi/10.1073/pnas.2000260117

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2000260117

journalhttps://doi.org/10.1073/pnas.2000260117

Fields of Study

HIV Research and TreatmentGlycosylation and Glycoproteins ResearchCytomegalovirus and herpesvirus research0301 basic medicine03 medical and health sciencesAntibodies, NeutralizingAntibody FormationComputer SimulationCryoelectron MicroscopyEpitopesGlycosylationHIV AntibodiesHIV Envelope Protein gp120HIV SeropositivityHIV-1HumansImmune EvasionMass SpectrometryModels, MolecularPolysaccharidesenv Gene Products, Human Immunodeficiency Virus

MeSH Terms

Antibody FormationEpitopesComputer SimulationGlycosylationHIV SeropositivityHumansModels, MolecularPolysaccharidesMass SpectrometryHIV AntibodiesHIV-1HIV Envelope Protein gp120Cryoelectron Microscopyenv Gene Products, Human Immunodeficiency VirusImmune EvasionAntibodies, Neutralizing

Keywords

GlycanGlycoproteinImmunogenicityComputational biologyEpitopeShieldChemistryGlycosylationBiologyCell biologyImmune systemBiochemistryGeneticsAntigenHIV-1Molecular modelingVaccineCryo-emModels, MolecularCryoelectron Microscopyenv Gene Products, Human Immunodeficiency VirusBiological SciencesHIV AntibodiesHIV Envelope Protein gp120Antibodies, NeutralizingHIV-1 | glycoprotein | cryo-EM | molecular modeling | vaccineMass SpectrometryEpitopesPolysaccharidesAntibody FormationHIV SeropositivityHumansComputer SimulationImmune Evasion

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Related Papers (10)

Modulating the quantity of HIV Env-specific CD4 T cell help promotes rare B cell responses in germinal centers

The Journal of Experimental Medicine(2020)

co-cited

10.1084/jem.20201254

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies

N/A

0.887DataRank · unranked

Nature reviews. Immunology(2022)

co-cited

10.1038/s41577-022-00753-w

Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key glycan barriers on HIV-1 Env

N/A

0.359DataRank · unranked

Journal of Virology(2024)

co-cited

10.1128/jvi.00744-24

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans

Cell(2024)

co-cited

10.1016/j.cell.2024.04.033

Cryo-ET of Env on intact HIV virions reveals structural variation and positioning on the Gag lattice

Cell(2022)

co-cited

10.1016/j.cell.2022.01.013

HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens

Cell Host & Microbe(2021)

co-cited

10.1016/j.chom.2021.05.012

Subnanometer structures of HIV-1 envelope trimers on aldrithiol-2-inactivated virus particles

N/A

0.675DataRank · unranked

Nature Structural & Molecular Biology(2020)

co-cited

10.1038/s41594-020-0452-2

Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature

Cell Reports(2020)

co-cited

10.1016/j.celrep.2020.107981

Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility

N/A

0.241DataRank · unranked

Nature Communications(2023)

co-cited

10.1038/s41467-023-42097-6

Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost

N/A

9.7DataRank · unranked

Nature(2022)

co-cited

10.1038/s41586-022-04778-y